AI assistant
Sending…
CYTOKINETICS INC — Director's Dealing 2025
Mar 18, 2025
30870_dirs_2025-03-17_0d8d01b9-d9f4-4e3b-9082-e6649b3de4aa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2025-03-17
Reporting Person: Malik Fady Ibraham (EVP Research & Development)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-17 | Common Stock | S | 4389 | $44.38 | Disposed | 101005 | Direct |
Footnotes
F1: Sell to cover transaction in connection with the vesting of restricted stock units.
More from CYTOKINETICS INC
Share Issue/Capital Change
2026
May 27
Declaration of Voting Results & Voting Rights Announcements
2026
May 27
Share Issue/Capital Change
2026
May 7
Report Publication Announcement
2026
May 5
Annual Report
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18